验证数据展示
经过测试的应用
Positive IHC detected in | mouse skin tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | HeLa cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
30628-1-AP targets NOD2 in IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
经测试应用 | IHC, IF/ICC, ELISA Application Description |
经测试反应性 | human, mouse |
免疫原 | NOD2 fusion protein Ag33771 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | nucleotide-binding oligomerization domain containing 2 |
别名 | CARD15, Caspase recruitment domain-containing protein 15, Nucleotide-binding oligomerization domain-containing protein 2 |
计算分子量 | 115 kDa |
GenBank蛋白编号 | NM_001293557 |
基因名称 | NOD2 |
Gene ID (NCBI) | 64127 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q9HC29 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
NOD2, also named as CARD15 and IBD1, induces NF-kappa-B via RICK (CARDIAK, RIP2) and IKK-gamma. It confers responsiveness to intracellular bacterial lipopolysaccharides (LPS). Defects in NOD2 are the cause of Blau syndrome (BS). Defects in NOD2 are a cause of susceptibility to Crohn disease (CD). Defects in NOD2 are a cause of susceptibility to ulcerative colitis. Defects in NOD2 are the cause of early-onset sarcoidosis (EOS).
实验方案
Product Specific Protocols | |
---|---|
IHC protocol for NOD2 antibody 30628-1-AP | Download protocol |
IF protocol for NOD2 antibody 30628-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |